Drugs / MESENDO
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 13 trials | ||||||
| Phase 1 | NCT00643981 | Feb → Dec 2008 | coronary atherosclerosis, myocardial ischemia | TCA Cellular Therapy | Completed | No outcome recorded |
| Phase 1 | NCT00548613 | Oct 2007 → Dec 2008 | coronary atherosclerosis | TCA Cellular Therapy | Completed | No outcome recorded |
| Phase 1 | NCT00518401 | Jun 2007 → Aug 2008 | limb ischemia, peripheral vascular disease | TCA Cellular Therapy | Completed | No outcome recorded |
| Phase 22 trials | ||||||
| Phase 2 | NCT00790764 | Nov 2008 → May 2014 | arterial occlusion, coronary atherosclerosis, myocardial ischemia | TCA Cellular Therapy | Suspended | No outcome recorded Stop: Business |
| Phase 2 | NCT00721006 | Jun 2008 → Aug 2010 | limb ischemia, peripheral arterial disease | TCA Cellular Therapy | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 5 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MESENDO | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00643981 ↗ |
| Modality | Cell therapy | “combination of stem cells” NCT00518401 ↗ |
| Route | Intramuscular | “Intramuscular injection” NCT00518401 ↗ |